skip to content

Cambridge Academy of Therapeutic Sciences

 

WT Developing Concept Fund

The Wellcome Trust has awarded Cambridge University an INSTITUTIONAL TRANSLATION PARTNERSHIP AWARD (iTPA).

The Developing Concept Fund is intended to pump-prime the translation of novel therapeutics, devices and diagnostics, including repurposing of existing therapies towards a clinical end. 

It is intended that successful project applicants will obtain evidence of the feasibility (or otherwise) of their translational plans, strengthening their chances of obtaining downstream funding. The focus will be on very early stage translational research and projects should be seen as a way to gain sufficient evidence to support follow on funding such as MRC CiC applications. Projects will be encouraged to include a substantive cross-disciplinary collaborative component between basic scientists, clinical scientists and/or industry (as appropraite for the project). Proposals must be led by a Principal Investigator at the University of Cambridge.

The fund supports projects up to a maximum of £50,000 each for 9 months..

 

This call is now CLOSED 

​Please email Cathy Boucher if you have any queries regarding your application.

 

Panel

The review panel includes:
  • Dr John Skidmore (Chair), Chief Scientific Officer ALBORADA Drug Discovery Institute
  • Prof Margaret Ashcroft, Department of Medicine
  • Prof Michael Sutcliffe, Theme Leader of Bioengineering
  • Dr Dave Smith, Principal Scientist, AstraZeneca
  • Mr Stuart Kay, Director Medtech Solutions Ltd
  • Prof David Jayne, Director of the Vasculitis and Lupus Service, Addenbrooke’s Hospital
  • Dr Tim Allsopp, Independent Consultant
  • Dr John Pritchard, Independent Consultant
  • Dr Neil Thompson, Independent Consultant
  • Prof Anne Willis, MRC Toxicology Unit, University of Cambridge
  • Prof Steve Charnock-Jones, Department of Obstetrics and Gynaecology
  • Prof Tim Eisen, Department of Oncology
  • Dr Stephanie Hopley, Apollo Therapeutics
  • Prof Narita Masashi, Cancer Research UK Cambridge Institute
  • Prof Tim Eisen, Department of Oncology
  • Prof Mark Toshner, Department of Medicine
  • Dr Sofia Villar, MRC Biostatistics Unit

Funded Projects in 2018

Name Department Title
Stephen Hofmann Department of Engineering Nanomaterial based sensor for rapid detection
Giovanna Mallucci Department of Clinical Neurosciences Developing a cell-based, high-throughput assay to repurpose drugs for the treatment of neurodegeneration
Jenny Gallop Gurdon Institute Targeting phosphoinositide metabolism to rebalance defective endocytosis in Lowe syndrome
Sadaf Farooqi Wellcome-MRC Institute of Metabolic Science Targeting obesity, type 2 diabetes and associated diseases
Matt Davis MRC Cognition and Brain Sciences Unit Auditory Brain-computer interfaces
Fiona Karet Cambridge Institute  for Medical Research Developing a low-cost, hand-held device
Ben Seymour Department of Engineering Chronic back pain therapeutics
Paul Conduit Department of Zoology Developing peptide-based inhibitors for targeting cancer

 

Projects funded in 2019

Name Department Title
Sebastian Pattinson Department of Engineering Enabling healthy motion and preventing injury through advanced orthoses
Clare Bryant Department of Medicine Targeting approaches for respiratory infection 
Sanjay Sinha Cambridge Stem Cell Institute  Novel strategy for improving cardiac function post-myocardial infarction
Margaret Ashcroft Department of Medicine Targeting cancer metabolism
David Fairen-Jimenez Department of Chemical Engineering and Biotechnology Novel approaches for targeting pancreatic cancer
Peter Arthur-Farraj Department of Clinical Neurosciences A novel therapy to promote peripheral nerve repair
David Summers Department of Genetics Improving the effectiveness of antibiotics
Jamie Blundell Department of Oncology Better blood-cancer risk prediction